cmml

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

Recruiting
  • Graft Vs Host Disease
  • +5 more
  • Augsburg, Germany
  • +15 more
Aug 2, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
Apr 4, 2022

AML/MDS, CMML, Relapse Trial in China, Spain, United States (LP-108, LP-108 and azacitidine)

Recruiting
  • AML/MDS
  • +5 more
  • Ann Arbor, Michigan
  • +7 more
Feb 14, 2022

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

CMML, Thrombocytopenia Trial in France (eltrombopag)

Completed
  • CMML
  • Thrombocytopenia
  • Amiens, France
  • +25 more
Apr 19, 2021

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

MDS, CMML Trial in Florence (CC-486)

Recruiting
  • MDS
  • CMML
  • Florence, Italy
    AOU Careggi- University of Florence
Mar 16, 2021

Ascorbic Acid Levels in MDS, AML, and CMML Patients

Completed
  • Myelodysplastic Syndromes
  • +5 more
  • Peripheral blood collection
  • Grand Rapids, Michigan
  • +1 more
Sep 30, 2019

AML, MDS, CMML Trial in United States (E6201)

Terminated
  • AML
  • +2 more
  • Denver, Colorado
  • +3 more
Mar 7, 2019